Results 181 to 190 of about 18,162 (243)

Breastfeeding on ART and a closer look at drug transfer to HIV-exposed uninfected infants. [PDF]

Sci Rep
Spielberger BD, Zink A, Rohr JC, Usadel S, Klinker H, Freudenhammer M, Elling R, Rieg S, Henneke P, Hufnagel M, Müller MC.   +10 more
europepmc   +1 more source

Short‐Course Raltegravir Intensification Does Not Reduce Persistent Low‐Level Viremia in Patients with HIV‐1 Suppression during Receipt of Combination Antiretroviral Therapy

, 2010
Deborah K. McMahon, Joyce Jones, A. Wiegand, Stephen J. Gange, Mary F. Kearney, Sarah Palmer, S. McNulty, Julia A. Metcalf, Edward P. Acosta, Catherine Rehm, John M. Coffin, John W. Mellors, Frank Maldarelli   +12 more
openalex   +2 more sources

How should APOBEC3-induced resistance mutations be considered in the management of antiretroviral therapy? [PDF]

J Antimicrob Chemother
Gilbert M, Ferré VM, Guilbaud R, Digumber M, Peytavin G, Damond F, Le Hingrat Q, Yazdanpanah Y, Descamps D, Charpentier C, Joly V, Ghosn J.   +11 more
europepmc   +1 more source

Repurposing raltegravir for reducing inflammation and treating cancer: a bioinformatics analysis. [PDF]

Sci Rep
Nikfarjam Z, Rakhshi R, Zargari F, Aalikhani M, Hasan-Abad AM, Bazi Z.   +5 more
europepmc   +1 more source

Noninvasive Markers of Hepatic Steatosis and Fibrosis Following Integrase Strand-Transfer Inhibitor Initiation in Women With HIV. [PDF]

Clin Infect Dis
Yu MA, Gerig L, Mehta CC, Musonge-Effoe J, Alvarez JA, Ofotokun I, Sheth AN, Ali MK, Ziegler TR, Yang Q, Spence AB, Alcaide ML, Dumond JB, Abraham AG, French AL, Augenbraun M, Anastos K, Price JC, Tien PC, Lahiri CD.   +19 more
europepmc   +1 more source

Antiretroviral medications for pediatric use in the context of the Unified Health System: are there therapeutic gaps in Brazil? [PDF]

Rev Paul Pediatr
Costa SMD, Aguiar PM.
europepmc   +1 more source

HIV-1 and SIV Infection are associated with early loss of lung interstitial CD4+ T cells and dissemination of pulmonary tuberculosis [PDF]

, 2019
et al,, Khader, Shabaana A
core   +1 more source

Avaliação da efetividade do uso de darunavir e/ou raltegravir e/ouenfuvirtida na supressão viral, resposta imunológica e fatoresassociados falha terapêutica em pacientes com infecção pelo HIV-1com ampla resistência aos antirretrovirais; estudo brasileiromulticêntrico, retrospectivo de 2005 a 2011.

, 2013
Mateus Rodrigues Westin
openalex   +1 more source

Mortality using raltegravir versus other integrase strand-transfer inhibitors in people with HIV in Europe and Australia: a prospective multicentre study. [PDF]

EClinicalMedicine
Tusch E, Ryom L, Hoffmann C, Degen O, Zangerle R, Günthard HF, Wit F, Mussini C, Castagna A, Martin C, Giacomelli A, Vehreschild JJ, Begovac J, Vannappagari V, Rooney J, Dos Santos Mendes S, Tallada J, Kowalska J, Wallner E, Kusejko K, Jaschinski N, Lundgren J, Peters L, Reekie J.   +23 more
europepmc   +1 more source

Determination of Raltegravir by derivative and difference spectrophotometric techniques in film coated tablets

, 2017
Mukthinuthalapati Mathrusri Annapurna, Gunnam Ravi Teja, Ponnekanti Krishna Phani, S Chaitanya   +3 more
openalex   +1 more source